Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
520.00    4.00 (0.78%)
Bid:
514.00
Ask:
520.00
Spread: 6.00 (1.167%)
Market Cap: £859.64m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Trading Update

31 Jan 2018 07:00

RNS Number : 4053D
Oakley Capital Investments Limited
31 January 2018
 

31 January 2018

 

Oakley Capital Investments Limited

 

Trading update for the twelve months ended 31 December 2017

 

Oakley Capital Investments Limited1 (AIM:OCI, the "Company"), which provides its shareholders with access to a portfolio of high quality companies through its investments in the Oakley Funds2, today announces a trading update for the 12 months ended 31 December 2017.

 

· NAV per share (unaudited) expected to be in the range of £2.43 - £2.45, representing an increase of at least 5% on December 2016 (£2.31)

· The Company has deployed £157.0m in the Oakley Funds and equity co-investments in 2017, during a period of significant investment

· The Company received £88.2m of distributions in the period

· Fund III closed at €800m in September 2017 of which the Company committed €326m

· Interim dividend of 2.25 pence, paid on 26 October 2017

 

Oakley Capital Limited ("Oakley Capital"), the Company's Investment Adviser, estimates that the Company's net asset value ("NAV"), which is subject to the completion of the 31 December 2017 audit of both the Oakley Funds and the Company, will be in the range of £498m to £502m, equating to a NAV per share of £2.43 to £2.45 (31 December 2016: £2.31).

 

Fund III has been active in deploying its capital and has invested €310.2m in five investments during the year, and completed another acquisition in January 2018 investing a further €84.6m. These portfolio companies represent investments in digital consumer, education and technology assets. The average entry EV/EBITDA multiple in Fund III, across all six assets, is currently 9.4x, reflecting the Investment Adviser's continued ability to access quality assets at attractive prices. OCI has an indirect interest in these portfolio companies through its 40.7% holding in Fund III.

 

During the year, the Company received £88.2m of distributions from the Oakley Funds and equity co-investments, relating to exits and refinancings.

 

The Company expects to report its annual results for 2017 on Thursday 15 March 2018.

 

 

- This announcement contains inside information -

 

 

For further information please contact:

 

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens, Director

Steven Tredget, Investor Relations

 

FTI Consulting LLP

+44 20 3727 1000

Edward Bridges / Stephanie Ellis

 

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Henry Freeman / Jill Li

 

 

1 About Oakley Capital Investments Limited ("OCI")

Oakley Capital Investments Limited is a Bermudian company listed on AIM. OCI seeks to provide investors with long term capital appreciation through its investment in Oakley Capital Private Equity L.P., Oakley Capital Private Equity II, Oakley Capital Private Equity III and through co-investment opportunities.

 

LEI Number: 213800KW6MZUK12CQ815

 

2 About Oakley Capital Private Equity L.P. ("Fund I"), Oakley Capital Private Equity II ("Fund II") and Oakley Capital Private Equity III ("Fund III") collectively the "Oakley Funds"

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II and Oakley Capital Private Equity III, are unlisted mid-market private equity funds with the aim of providing investors with significant long term capital appreciation. The investment strategy of the funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSDFEESFASEEF
Date   Source Headline
14th Mar 20245:32 pmRNSDividend Declaration
14th Mar 20247:00 amRNSAnnual Results 2023
4th Mar 20247:00 amRNSNotice of Results and Investor Presentation
15th Feb 20247:00 amRNSAppointment of Financial Adviser
13th Feb 20247:00 amRNSDirector Dealing
13th Feb 20247:00 amRNSDirector Dealing
24th Jan 20247:00 amRNSTrading Statement
16th Jan 20247:00 amRNSOakley agrees investment in Steer Automotive Group
15th Jan 20247:00 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSSettlement of Fund I Loan
20th Dec 20239:39 amRNSUpdate from QuotedData
20th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20232:39 pmRNSResult of AGM
21st Nov 20237:00 amRNSDirector Dealing
7th Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
30th Oct 20237:00 amRNSNotice of AGM and Directorate Change
30th Oct 20237:00 amRNSInvestment in Alerce
26th Oct 202311:14 amRNSInvestment in Webcentral
25th Oct 20237:00 amRNSTrading update for the 3 months ended 30 Sep 2023
18th Oct 20237:00 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSHolding(s) in Company
14th Sep 20235:53 pmRNSInterim Results 2023 - Replacement
14th Sep 20237:00 amRNSInterim Results for the 6 months ended 30 June 23
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSOakley invests in three dental labs businesses
31st Jul 202312:14 pmRNSDirector Dealing
28th Jul 20232:27 pmRNSDirector Dealing
26th Jul 20237:00 amRNSTrading update for the 6 months ended 30 June 2023
26th Jun 20237:00 amRNSDirector Dealing
26th Jun 20237:00 amRNSDirector Dealing
19th Jun 202311:44 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
17th May 20238:04 amRNSOakley Capital extends IU Group partnership
10th May 20237:00 amRNSSale and Reinvestment in IU Group
26th Apr 20237:00 amRNSTrading update for the 3 months ended 31 Mar 2023
18th Apr 20237:00 amRNSOakley partners with schools group Thomas's
4th Apr 20231:13 pmRNSInitiation from QuotedData
31st Mar 20238:00 amEQSHardman & Co Q&A on Oakley Capital Investments (OCI): 2022 Results: EBITDA Growth Drives NAV Appreciation
16th Mar 20237:00 amRNSDirector Dealing
15th Mar 20237:15 amEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): 2022: NAV returns driven by EBITDA growth
9th Mar 20237:00 amRNSFinal Results for the Year Ended 31 December 2022
27th Feb 20237:00 amRNSNotice of Results and Investor Presentation
25th Jan 20237:00 amRNSTrading update for the year ended 31 December 2022
18th Jan 20234:19 pmRNSHolding(s) in Company
18th Jan 20234:19 pmRNSHolding(s) in Company
18th Jan 20232:15 pmEQSHardman & Co Q&A on Oakley Capital Investments Ltd (OCI): High-growth drivers in 2023
15th Dec 20227:00 amRNSOCI commits EUR 30m to Oakley PROfounders III

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.